Orange Biomed Attracts $1.6B Won in Pre-Series A Investment Round from Seoul New Technology Investment Company and Digital Healthcare Partners

‘Orange Biomed’, a diabetes in vitro diagnostic medical device startup, attracted 1.6 billion won in pre-Series A round investment…

Subscribe to Our Monthly Newsletter